| Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection N Afdhal, S Zeuzem, P Kwo, M Chojkier, N Gitlin, M Puoti, ... New England Journal of Medicine 370 (20), 1889-1898, 2014 | 2165 | 2014 |
| Statements from the Taormina expert meeting on occult hepatitis B virus infection G Raimondo, JP Allain, MR Brunetto, MA Buendia, DS Chen, M Colombo, ... Journal of hepatology 49 (4), 652-657, 2008 | 1140 | 2008 |
| A meta‐analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma F Donato, P Boffetta, M Puoti International journal of cancer 75 (3), 347-354, 1998 | 733 | 1998 |
| EASL recommendations on treatment of hepatitis C: final update of the series☆ JM Pawlotsky, F Negro, A Aghemo, M Berenguer, O Dalgard, G Dusheiko, ... Journal of hepatology 73 (5), 1170-1218, 2020 | 727 | 2020 |
| Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 … VC Marconi, AV Ramanan, S de Bono, CE Kartman, V Krishnan, R Liao, ... The lancet Respiratory medicine 9 (12), 1407-1418, 2021 | 681 | 2021 |
| A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel M Cornberg, HA Razavi, A Alberti, E Bernasconi, M Buti, C Cooper, ... Liver International 31, 30-60, 2011 | 589 | 2011 |
| EASL recommendations on treatment of hepatitis C 2018 JM Pawlotsky, F Negro, A Aghemo, M Berenguer, O Dalgard, G Dusheiko, ... Journal of hepatology 69 (2), 461-511, 2018 | 487 | 2018 |
| Glecaprevir–pibrentasvir for 8 or 12 weeks in HCV genotype 1 or 3 infection S Zeuzem, GR Foster, S Wang, A Asatryan, E Gane, JJ Feld, T Asselah, ... New England Journal of Medicine 378 (4), 354-369, 2018 | 483 | 2018 |
| Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV–HIV International Panel V Soriano, M Puoti, M Sulkowski, A Cargnel, Y Benhamou, M Peters, ... Aids 21 (9), 1073-1089, 2007 | 463 | 2007 |
| Update of the statements on biology and clinical impact of occult hepatitis B virus infection G Raimondo, S Locarnini, T Pollicino, M Levrero, F Zoulim, AS Lok, ... Journal of hepatology 71 (2), 397-408, 2019 | 424 | 2019 |
| Selective Depletion in HIV Infection of T Cells that Bear Specific T Cell Receptor Vβ Sequences L Imberti, A Sottini, A Bettinardi, M Puoti, D Primi Science 254 (5033), 860-862, 1991 | 410 | 1991 |
| Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2 … P Cahn, JS Madero, JR Arribas, A Antinori, R Ortiz, AE Clarke, CC Hung, ... The Lancet 393 (10167), 143-155, 2019 | 405 | 2019 |
| European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV‐infected adults JK Rockstroh, S Bhagani, Y Benhamou, R Bruno, S Mauss, L Peters, ... HIV medicine 9 (2), 82-88, 2008 | 320 | 2008 |
| Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome M Puoti, R Bruno, V Soriano, F Donato, GB Gaeta, GP Quinzan, ... Aids 18 (17), 2285-2293, 2004 | 320 | 2004 |
| Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects A De Luca, R Bugarini, AC Lepri, M Puoti, E Girardi, A Antinori, A Poggio, ... Archives of internal medicine 162 (18), 2125-2132, 2002 | 317 | 2002 |
| Incidence and Predictors of Severe Liver Fibrosis in Human Immunodeficiency Virus—Infected Patients with Chronic Hepatitis C: A European Collaborative Study L Martín-Carbonero, Y Benhamou, M Puoti, J Berenguer, J Mallolas, ... Clinical Infectious Diseases 38 (1), 128-133, 2004 | 313 | 2004 |
| Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV–HBV International Panel V Soriano, M Puoti, M Bonacini, G Brook, A Cargnel, J Rockstroh, C Thio, ... Aids 19 (3), 221-240, 2005 | 312 | 2005 |
| Natural history of chronic hepatitis B in co-infected patients M Puoti, C Torti, R Bruno, G Filice, G Carosi Journal of hepatology 44, S65-S70, 2006 | 308 | 2006 |
| Mortality for liver disease in patients with HIV infection: a cohort study M Puoti, A Spinetti, A Ghezzi, F Donato, S Zaltron, V Putzolu, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 24 (3), 211-217, 2000 | 304 | 2000 |
| Prophylaxis and treatment of hepatitis B in immunocompromised patients A Marzano, E Angelucci, P Andreone, M Brunetto, R Bruno, P Burra, ... Digestive and Liver Disease 39 (5), 397-408, 2007 | 285 | 2007 |
